How many biotech companies are in Aarhus?

Aarhus hosts 3 verified life-science companies in this directory — spanning Therapeutics, Biotech. The exact count appears in the page header above and updates with each directory refresh.

What are the leading biotech companies in Aarhus?

Aarhus's anchor companies include Commit Biologics ApS, NMD Pharma A/S, STipe Therapeutics ApS. Each is hand-reviewed against primary leadership sources, a verified physical address, and regulatory certifications.

City page

Aarhus biotech and pharma directory

Aarhus is a life-science cluster in Denmark with 3 verified companies in this directory, spanning Therapeutics, Biotech. Its anchor companies include Commit Biologics ApS, NMD Pharma A/S, STipe Therapeutics ApS. Every profile is hand-reviewed against leadership sources, a verified physical address, and regulatory certifications.

Evidence

Visible records3

Verified3

Categories2

Regulated sites0

Avg sources / record0.0

City view

Where does this city read strongest?

Therapeutics (2) and Biotech (1). Most visible records: Commit Biologics ApS, NMD Pharma A/S, and STipe Therapeutics ApS.

City view

Which standards and public evidence are already visible?

Not yet available.. Latest review: 24 April 2026. Review cycle: April 2026.

City view

Why does this city matter?

This page brings visible companies and infrastructure records into one practical view of Aarhus.

By category

Aarhus by category

Jump into a category page filtered to this country only.

Therapeutics (2)

Full list

Aarhus biotech and pharma directory

3 city records currently match the active filter.

Aarhus preclinical biotech building complement-powered immune-engager biologics through the BiCE Complement Engager platform, with a 2025 non-human primate proof-of-concept milestone and a newly named CEO from March 2026.

Lead: Thomas L. F. Montgomery AndresenChief Executive Officer
Scale: Preclinical biotech development

Aarhus clinical-stage neuromuscular biotech developing ClC-1 chloride-channel inhibitors to restore muscle function, with lead candidate NMD670 in Phase 2 for myasthenia gravis.

Lead: Thomas Holm PedersenCo-Founder and Chief Executive Officer
Scale: Clinical-stage small-molecule development

Aarhus preclinical immuno-oncology biotech developing STING-pathway priming small molecules to convert cold tumors into immune-responsive ones, with a 20 million EUR Series A financing completed in 2019.

Lead: Claus Elsborg OlesenCo-Founder and Chief Executive Officer
Scale: Preclinical small-molecule development

FAQ

Frequently asked questions

How many biotech companies are in Aarhus?: Aarhus hosts 3 verified life-science companies in this directory — spanning Therapeutics, Biotech. The exact count appears in the page header above and updates with each directory refresh.
What are the leading biotech companies in Aarhus?: Aarhus's anchor companies include Commit Biologics ApS, NMD Pharma A/S, STipe Therapeutics ApS. Each is hand-reviewed against primary leadership sources, a verified physical address, and regulatory certifications.

Related briefs

Briefs that mention Aarhus

Market brief

Nordic Biotech Landscape 2026: Denmark, Sweden, Finland, Norway

A practical map of the Nordic biotech and pharma landscape in 2026 — 124 operators across Denmark, Sweden, Finland, and Norway, anchored by Novo Nordisk, Genmab, Lundbeck, AstraZeneca Gothenburg, Bavarian Nordic, Orion, and a dense Medicon Valley + Karolinska cluster layer.

Open brief

Next step

Read the city, then widen the view.

Use country and regional pages for wider context, and the company suggestion form for new candidate records.

Open country page Suggest a company